REVIEW article
Front. Cell. Infect. Microbiol.
Sec. Clinical and Diagnostic Microbiology and Immunology
This article is part of the Research TopicAssessing Nosocomial Fungal Infections: Virulence and Resistance DynamicsView all 5 articles
Epidemiological shifts and advances in research on early diagnosis of invasive fungal infection in critically ill patients
Provisionally accepted
- 1st Medical Center of Chinese PLA General Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Invasive fungal infections (IFI) primarily occur in immunocompromised patients, particularly those in intensive care units (ICU). Due to the use of immunosuppressive agents, invasive therapeutic procedures, and advancements in diagnostic technologies, the detection rate of IFI has shown a significant upward trend. This review aims to explore epidemiological changes in the field of IFI, early detection techniques, and the application of artificial intelligence (AI) technologies. We conducted a literature review using PubMed data up to April 2025, focusing on studies related to IFI. Specifically, we focus on three aspects of IFI research: first, the epidemiology of IFI is undergoing significant changes, with Candida auris rapidly spreading across more than 40 countries worldwide, and rare fungal infections such as Mucor spp. and Fusarium spp. becoming increasingly prevalent; simultaneously, resistance to antifungal drugs among various pathogens continues to rise. Second, breakthroughs have been achieved in early detection technologies, including molecular detection techniques, biomarker testing, imaging technologies, and other emerging diagnostic methods, significantly enhancing the sensitivity and specificity of diagnosis. Thirdly, with the widespread application of AI technology, the development of clinical predictive models, the establishment of scoring rules, and the formulation of AI-based treatment decision-making tools are advancing the exploration of early diagnosis for IFI. In summary, as early diagnostic technologies for IFI continue to advance and AI algorithms are integrated into clinical practice, there is potential to improve the early diagnosis and treatment outcomes for critically ill patients with IFI.
Keywords: Aspergillosis, Candidiasis, Fungal detection, Intensive Care Unit, Invasive fungal infection
Received: 04 Aug 2025; Accepted: 27 Nov 2025.
Copyright: © 2025 Cao, Li, Wang, Wu, Shi, Wang, Gao, Yang, Wang and Kang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hongjun Kang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.